Management of prosthetic heart valve complications

Current Treatment Options in Cardiovascular Medicine

Volumn 14, Issue 6, 2012, Pages 608-621

  Mankad, Sunil ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

Echocardiography; Prosthesis; Prosthetic heart valve; Valve dysfunction

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTIBIOTIC PROPHYLAXIS; ANTICOAGULATION; ARTICLE; BACTERIAL ENDOCARDITIS; CLINICAL CLASSIFICATION; EMBOLISM; FIBRINOLYTIC THERAPY; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HEART VALVE REGURGITATION; HEART VALVE REPLACEMENT; HEMODYNAMICS; HEMOLYTIC ANEMIA; HIGH RISK PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LONG TERM CARE; MEDICAL ERROR; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PREGNANT WOMAN; PROSTHESIS PATIENT MISMATCH; PROSTHETIC HEART VALVE REGURGITATION; PROSTHETIC VALVE ENDOCARDITIS; REOPERATION; STAPHYLOCOCCUS INFECTION; THROMBOEMBOLISM; THROMBOSIS; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 84870297282     PISSN: 10928464     EISSN: 15343189     Source Type: Journal    
DOI: 10.1007/s11936-012-0212-7     Document Type: Article

References (68)

1. Harken DE, Soroff HS, Taylor WJ, Lefemine AA, Gupta SK, Lunzer S. Partial and complete prostheses in aortic insufficiency. J Thorac Cardiovasc Surg. 1960;40:744-62.
2. Suri RM, Schaff HV, Dearani JA, et al. Survival advantage and improved durability of mitral repair for leaflet prolapse subsets in the current era. Ann Thorac Surg. 2006;82:819-26.
3. Yacoub MH, Takkenberg JJ. Will heart valve tissue engineering change the world? Nature clinical practice. Cardiovasc Med. 2005;2:60-1. (Pubitemid 40778851)
4. Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. N Engl J Med. 1996;335:407-16. (Pubitemid 26257250)
5. Hammermeister KE, Sethi GK, Henderson WG, Oprian C, Kim T, Rahimtoola S. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease. N Engl J Med. 1993;328:1289-96. (Pubitemid 23131369)
6. Hammermeister KE, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical vs a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol. 2000;36:1152-8.
7. Khan S, Chaux A, Matloff J, Blanche C, DeRobertis M, Kass R, et al. The St. Jude Medical valve. Experience with 1000 cases. J Thorac Cardiovasc Surg. 1994;108:1010-9.
8. Otto CM. Prosthetic heart valves. In: Otto CM, editor. Valvular heart disease. Philadelphia: WB Saunders; 2004. p. 437-81.
9. Panidis IP, Ross J, Mintz GS. Normal and abnormal prosthetic valve function as assessed by Doppler echocardiography. J Am Coll Cardiol. 1986;8:317-26. (Pubitemid 16036465)
10. Zoghbi WA, Chambers JB, Dumesnil JG, et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr: official publication of the American Society of Echocardiography. 2009;22:975-1014. quiz 1082-1014 .
11. Baumgartner H, Khan S, DeRobertis M, Czer L, Maurer G. Discrepancies between Doppler and catheter gradients in aortic prosthetic valves in vitro. A manifestation of localized gradients and pressure recovery. Circulation. 1990;82:1467-75.
12. Khandheria BK. Transesophageal echocardiography in the evaluation of prosthetic valves. Cardiol Clin. 1993;11:427-36. (Pubitemid 23259699)
13. Sorajja P, Cabalka AK, Hagler DJ, Rihal CS. Percutaneous repair of paravalvular prosthetic regurgitation: acute and 30-day outcomes in 115 patients. Circ Cardiovasc Intervent. 2011;4:314-21.
14. Sorajja P, Cabalka AK, Hagler DJ, Rihal CS. Longterm follow-up of percutaneous repair of paravalvular prosthetic regurgitation. J Am Coll Cardiol. 2011;58:2218-24.
15. Ruiz CE, Jelnin V, Kronzon I, et al. Clinical outcomes in patients undergoing percutaneous closure of periprosthetic paravalvular leaks. J Am Coll Cardiol. 2011;58:2210-7.
16. Webb JG, Wood DA, Ye J, et al. Transcatheter valvein-valve implantation for failed bioprosthetic heart valves. Circulation. 2010;121:1848-57 .
17. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006;114: e84-e231. (Pubitemid 44268973)
18. Carpentier A, Dubost C, Lane E, Nashef A, Carpentier S, Relland J, et al. Continuing improvements in valvular bioprostheses. J Thorac Cardiovasc Surg. 1982;83:27-42. (Pubitemid 12209548)
19. Blair KL, Hatton AC, White WD, Smith LR, Lowe JE, Wolfe WG, et al. Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement. Circulation. 1994;90(5 Pt 2): II214-9. (Pubitemid 24349273)
20. Lee YP, Schommer JC. Effect of a pharmacist-managed anticoagulation clinic on warfarin-related hospital readmissions. Am J Health Syst Pharm. 1996;53:1580-3. (Pubitemid 26243390)
21. Hung L. Prosthetic heart valves and pregnancy. Circulation. 2003;107:1240-6. (Pubitemid 36314404)
22. McLintock C. Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: no easy option. Thromb Res. 2011;127:S56-60.
23. Salazar E, Izaguirre R, Verdejo J, Mutchinick O. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses. J Am Coll Cardiol. 1996;27:1698-703. (Pubitemid 126334709)
24. Castellano JM, Narayan RL, Vaishnava P, Fuster V. Anticoagulation during pregnancy in patients with a prosthetic heart valve. Nat Rev Cardiol. 2012;9:415-24
25. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med. 2000;160:191-6. (Pubitemid 30054338)
26. Cannegieter SC, Rosendaal FR, Briët E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation. 1994;89:635-41. (Pubitemid 24056190)
27. Hammermeister KE, Henderson WG, Burchfiel CM, Sethi GK, Souchek J, Oprian C, et al. Comparison of outcome after valve replacement with a bioprosthesis vs a mechanical prosthesis: initial 5 year results of a randomized trial. J Am Coll Cardiol. 1987;10:719-32. (Pubitemid 17163094)
28. Orszulak TA, Schaff HV, Puga FJ, Danielson GK, Mullany CJ, Anderson BJ, et al. Event status of the Starr-Edwards aortic valve to 20 years: a bench-mark for comparison. Ann Thorac Surg. 1997;63:620-6. (Pubitemid 27128669)
29. Turpie AG, Gent M, Laupacis A, Latour Y, Gunstensen J, Basile F, et al. A comparison of aspirin with placebo in patients treated with warfarin after heartvalve replacement. N Engl J Med. 1993;329:524-9. (Pubitemid 23232620)
30. Gödje OL, Fischlein T, Adelhard K, Nollert G, Klinner W, Reichart B. Thirty-year results of Starr-Edwards prostheses in the aortic and mitral position. Ann Thorac Surg. 1997;63:613-9. (Pubitemid 27128668)
31. Debétaz LF, Ruchat P, Hurni M, Fischer A, Stumpe F,Sadeghi H, et al. St. Jude Medical valve prosthesis: an analysis of long-term outcome and prognostic factors. J Thorac Cardiovasc Surg. 1997;113:134-48. (Pubitemid 27034352)
32. Cannegieter SC, van der Meer FJ, Briët E, Rosendaal FR. Warfarin and aspirin after heart-valve replacement. N Engl J Med. 1994;330:507-8.
33. Ibrahim M, O'Kane H, Cleland J, Gladstone D, Sarsam M, Patterson C. The St. Jude Medical prosthesis. A thirteen-year experience. J Thorac Cardiovasc Surg. 1994;108:221-30. (Pubitemid 24258661)
34. Becker RC, Eisenberg P, Turpie AG. Pathobiologic features and prevention of thrombotic complications associated with prosthetic heart valves: fundamental principles and the contribution of platelets and thrombin. Am Heart J. 2001;141:1025-37. (Pubitemid 32477017)
35. Deviri E, Sareli P, Wisenbaugh T, Cronje SL. Obstruction of mechanical heart valve prosotheses: clinical aspects and surgical management. J Am Coll Cardiol. 1991;17:646.
36. Lengyel M. Diagnosis and treatment of left-sided prosthetic valve thrombosis. Expert Rev Cardiovasc Ther. 2008;6:85-93
37. Roudaut R, Lafitte S, Roudaut MF, Courtault C, Perron JM, Jaïs C, et al. Fibrinolysis of mechanical prosthetic valve thrombosis: a single-center study of 127 cases. J Am Coll Cardiol. 2003;41:653-8. (Pubitemid 36223332)
38. Tong AT, Roudaut R, Ozkan M, Sagie A, Shahid MS, Pontes Júnior SC, et al. Transesophageal echocardiography improves risk assessment of thrombolysis of prosthetic valve thrombosis: results of the international PRO-TEE registry. J Am Coll Cardiol. 2004;43:77-84. (Pubitemid 38045919)
39. Rahimtoola SH. The problem of valve prosthesispatient mismatch. Circulation. 1978;58:20-4
40. Blais C, Dumesnil JG, Baillot R, Simard S, Doyle D, Pibarot P. Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement. Circulation. 2003;108:983-8. (Pubitemid 37048229)
41. Head SJ, Mokhles MM, Osnabrugge RL, Pibarot P, Mack MJ, Takkenberg JJ, et al. The impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: a systematic review and meta-analysis of 34 observational studies comprising 27,186 patients with 133,141 patient-years. Eur Heart J. 2012;33:1518-29.
42. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116: 1736-54.
43. Nishimura RA, Carabello BA, Faxon DP, et al. ACC/ AHA 2008 Guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography, and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52:676-85.
44. Grover FL, Cohen DJ, Oprian C, Henderson WG, Sethi G, Hammermeister KE. Determinants of the occurrence of and survival from prosthetic valve endocarditis. Experience of the Veterans Affairs Cooperative Study on Valvular Heart Disease. J Thorac Cardiovasc Surg. 1994;108:207-14. (Pubitemid 24258659)
45. Thevenet A, Albat B. Long term follow up of 292 patients after valve replacement with the Omni-carbon prosthetic valve. Heart Valve Dis. 1995;4: 634-9.
46. Wolff M, Witchitz S, Chastang C, Régnier B, Vachon F. Prosthetic valve endocarditis in the ICU. Prognosticfactors of overall survival in a series of 122 cases and consequences for treatment decision. Chest. 1995;108:688-94.
47. Horstkotte D, Piper C, Niehues R, Wiemer M, Schultheiss HP. Late prosthetic valve endocarditis. Eur Heart J. 1995;16(Suppl B):39-47.
48. Fang G, Keys TF, Gentry LO, Harris AA, Rivera N, Getz K, et al. Prosthetic valve endocarditis resulting from nosocomial bacteremia. A prospective, multicenter study. Ann Intern Med. 1993;119(7 Pt 1):560-7. (Pubitemid 23311256)
49. Daniel WG, Mügge A, Grote J, Hausmann D, Nikutta P, Laas J, et al. Comparison of transthoracic and transesophageal echocardiography for detection of abnormalities of prosthetic and bioprosthetic valves in the mitral and aortic positions. Am J Cardiol. 1993;71:210-5. (Pubitemid 23030646)
50. Karchmer AW, Bisno AL. Infections of prosthetic heart valves and vacular grafts. In: Bisno AL, Waldovogel FA, editors. Infections associated with indwelling medical devices. Washington DC: American Society for Microbiology; 1989. p. 129-59.
51. Yu VL, Fang GD, Keys TF, Harris AA, Gentry LO, Fuchs PC, et al. Prosthetic valve endocarditis: superiority of surgical valve replacement vs medical therapy only. Ann Thorac Surg. 1994;58:1073-7. (Pubitemid 24342433)
52. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, et al. Early surgery vs conventional treatment for infective endocarditis. N Engl J Med. 2012;366:2466-73.
53. Kim DH, Kang DH, Lee MZ, Yun SC, Kim YJ, Song JM, et al. Impact of early surgery on embolic events in patients with infective endocarditis. Circulation. 2010;122(11 Suppl):S17-22.
54. Gutierrez-Martin MA, Galvez-Aceval J, Araji OA. Indications for surgery and operative techniques in infective endocarditis in the present day. Infect Disord Drug Targets. 2010;10:32-46.
55. Derex L, Bonnefoy E, Delahaye F. Impact of stroke on therapeutic decision making in infective endocarditis. J Neurol. 2010;257:315-21.
56. Yau JW, Lee P, Wilson A, Jenkins AJ. Prosthetic valve endocarditis: what is the evidence for anticoagulant therapy? Int Med J. 2011;41:795-7.
57. McClure RS, Narayanasamy N, Wiegerinck E, Lipsitz S, Maloney A, Byrne JG, et al. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1000 patients. Ann Thorac Surg. 2010;89:1410-6.
58. Burdon TA, Oyer PE, Mitchell RS, Stinson EB, Starnes VA, Shumway NE. Durability of porcine valves fifteen years in a representative North American patient population. J Thorac Cardiovasc Surg. 1992;103:238-51.
59. Bianchi G, Solinas M, Bevilacqua S, Glauber M. Are bioprostheses associated with better outcome than mechanical valves in patients with chronic kidney disease requiring dialysis who undergo valve surgery? Interact Cardiovasc Thorac Surg. 2012;15:473-83.
60. Chan V, Jamieson WR, Fleisher AG, Denmark D, Chan F, Germann E. Valve replacement surgery in end-stage renal failure: mechanical prostheses vs bioprostheses. Ann Thorac Surg. 2006;81:857-62. (Pubitemid 43247650)
61. PeterseimDS, Cen YY, Cheruvu S, Landolfo K, Bashore TM, Lowe JE, et al. Long-termoutcome after biologic vs mechanical aortic valve replacement in 841 patients. J Thorac Cardiovasc Surg. 1999;117:890-7. (Pubitemid 29210771)
62. Michelena HI, Alli O, Cabalka AK, Rihal CS. Successful percutaneous transvenous antegrade mitral valve-in-valve implantation. Catheter Cardiovasc Interv. 2012:1-6.
63. Dávila-Román VG, Waggoner AD, Kennard ED, Holubkov R, Jamieson WR, Englberger L, et al. Prevalence and severity perivalvular regurgitation in the artificial valve endocarditis reduction trial (AVERT) echocardiography study. J Am Coll Cardiol. 2004;44:1467-72. (Pubitemid 39303950)
64. Mecozzi G, Milano AD, De Carlo M, Sorrentino F, Pratali S, Nardi C, et al. Intravascular hemolysis in patients with new-generation prosthetic heart valves: a prospective study. J Thorac Cardiovasc Surg. 2002;123:550-6.
65. Garcia MJ, Vandervoort P, Stewart WJ, Lytle BW, Cosgrove 3rd DM, Thomas JD, et al. Mechanisms of hemolysis with mitral prosthetic regurgitation. Study using transesophageal echocardiography and fluid dynamic simulation. J Am Coll Cardiol. 1996;27:399-406.
66. Yeo TC, Freeman WK, Schaff HV, Orszulak TA. Mechanisms of hemolysis after mitral valve repair: assessment by serial echocardiography. J Am Coll Cardiol. 1998;32:717-23. (Pubitemid 28435259)
67. Miller DL, Morris JJ, Schaff HV, Mullany CJ, Nishimura RA, Orszulak TA. Reoperation for aortic valve periprosthetic leakage: identification of patients at risk and results of operation. J Heart Valve Dis. 1995;4:160-5. (Pubitemid 26021273)
68. Akins CW, Bitondo JM, Hilgenberg AD, Vlahakes GJ, Madsen JC, MacGillivray TE. Early and late results of the surgical correction of cardiac prosthetic paravalvular leaks. J Heart Valve Dis. 2005;14:192-9.